06/17/2025
6:07 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
3:23 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
6:01 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
7:57 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
4:31 PM | Mineralys Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
6:01 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
3:11 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2025
7:16 AM | Mineralys Therapeutics (Filer)
| Form DEF 14A | |
04/09/2025
7:18 AM | Mineralys Therapeutics (Filer)
| Form DEFA14A | |
04/09/2025
7:21 AM | Mineralys Therapeutics (Filer)
| Form ARS | |
04/03/2025
4:36 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MLYS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/01/2025
3:44 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/31/2025
7:15 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
8:04 PM | AKKARAJU SRINIVAS (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
8:05 PM | Mineralys Therapeutics (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
8:06 PM | Mineralys Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/17/2025
6:56 PM | Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
6:58 PM | Mineralys Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/13/2025
4:15 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
6:05 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
8:41 PM | Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:58 PM | Mineralys Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:58 PM | Karydas Daphne (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:58 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:59 PM | Gold Alexander M (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:59 PM | DiRocco Derek (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:59 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:59 PM | AKKARAJU SRINIVAS (Reporting)
Mineralys Therapeutics (Issuer)
Samsara BioCapital, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:59 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:59 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:03 AM | Mineralys Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
5:03 AM | ADAMS STREET PARTNERS LLC (Filed by)
Mineralys Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
4:29 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
6:07 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
7:05 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
8:44 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
8:45 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
8:46 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
5:21 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
5:34 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
7:07 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad) Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.”
We recently sat down with Rickards to capture all the key details on tape.
 For the moment, you can watch this interview free of charge – just click here. |
01/07/2025
4:58 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:37 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
9:40 AM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
5:43 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
7:03 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
3:21 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:22 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:22 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:48 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:54 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2024
7:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
3:32 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:20 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:45 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:50 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
5:34 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:41 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:37 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:39 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:51 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024
3:53 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
